New Drug Approved for Childhood Leukemia
301333
NEW YORK  - Genzyme Corp. announced  Wednesday that its drug Clolar has been approved by the U.S.  Food and Drug Administration (FDA) for the treatment of  children with difficult or relapsed acute lymphoblastic  leukemia (ALL).
516652
A panel of medical experts on Wednesday said Ilex Oncology Inc.&#39;s new drug Clolar was &quot;reasonably likely&quot; to help children and young adults with acute lymphocytic leukemia.
394537
A breakthrough cancer drug made by a Long Island company won federal approval late Thursday in a major victory for cancer patients and the region&#39;s budding biotech industry.
263089
A Merck &amp; Co. Inc. drug received federal approval Friday to treat a slow-growing cancer that affects infection-fighting white blood cells.
352867
Weeks before pharmaceutical giant Merck &amp; Co. sent seismic waves through the medical community, pulling its painkiller Vioxx off the market, it announced the drug had been approved for children.
536259
Genzyme Corp.'s not-yet-completed $1 billion acquisition of Ilex Oncology Inc. appeared to pay off yesterday when an advisory committee to the Food and Drug Administration recommended the agency approve Ilex's experimental cancer treatment for children with certain types of leukemia.
353899
Clolar, a new drug to treat childhood leukemia, should receive government approval, a US Food and Drug Administration advisory panel recommended Wednesday.
368106
Researchers have discovered a genetic mutation that causes an aggressive form of childhood leukemia and said on Thursday it may mean that drugs being developed for Alzheimer's disease could also provide a better treatment for the cancer.
709219
A panel of medical experts on Wednesday said Ilex Oncology Inc.'s new drug Clolar was "reasonably likely" to help children and young adults with a cancer called acute lymphocytic leukemia.
713941
GlaxoSmithKline Plc  has bought global rights to Danish biotech company Genmab's  most promising new drug, a treatment for leukemia, in a record deal worth up to $2.1 billion, the two firms said on Tuesday.
63488
PARIS - Nov. 6, 2004 â-he FDA has approved a new application for the anticancer drug oxaliplatin for use in treating colon cancer after surgery and in combination with another chemotherapy drug.
640929
Shares of Cambridge-based Genzyme were up slightly today on news that the drug maker won approval for a drug to treat childhood leukemia.
671018
Thalidomide received federal approval Thursday for treatment of bone-marrow cancer, marking the further rehabilitation of a drug originally banned more than 40 years ago after it caused thousands of birth defects.
555792
A panel of medical experts on Wednesday said Ilex Oncology Inc.&#39;s new drug Clolar was &quot;reasonably likely&quot; to help children and young adults with a cancer called acute lymphocytic leukemia.
379052
A next-generation leukemia pill  designed to help patients not cured by the successful drug  Gleevec works even better than doctors had hoped, researchers  said Sunday.
688289
The Food and Drug Administration approved Clolar, Genzyme Corp.'s new drug for patients under 21 with acute lymphocytic leukemia. An advisory panel on Dec. 1 recommended the drug be approved. Clolar was developed by Ilex Oncology Inc., the Texas firm Cambridge-based Genzyme acquired last week in a $1 billion stock transaction. The FDA panel recommended that more studies be done ...
497020
Researchers have discovered a genetic mutation that causes an aggressive form of childhood leukemia and said on Thursday it may mean that drugs being developed for Alzheimer&#39;s disease could also provide a better treatment for